Fifth, conduct drug development and clinical trials based on the SIRT1-ER stress-NF-κB pathway to promote its application in the prevention and treatment of metabolic diseases, cardiovascular and cerebrovascular diseases, neurodegenerative diseases, and inflammatory diseases. The gene discussed is SIRT1; the disease is metabolic disease.